The VEGF/Rho GTPase signalling pathway: A promising target for anti-angiogenic/anti-invasion therapy
Roy van der Meel(Eindhoven University of Technology), Annette T. Byrne(Royal College of Surgeons in Ireland), Raymond M. Schiffelers(University Medical Center Utrecht), Marc Symons(Feinstein Institute for Medical Research), Robert Kudernatsch(Charité - Universitätsmedizin Berlin), William M. Gallagher(University College Dublin), Gert Storm(Yong In University), Robbert J. Kok(Utrecht University)
Cited by 74
Related Papers
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
The current landscape of nucleic acid therapeutics
|Nature Nanotechnology|2021|1.3k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k